Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-13
2007-11-13
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S158000
Reexamination Certificate
active
10524798
ABSTRACT:
A compound of formula (I) (I) wherein R is H; Ar is an aromatic group selected from phenyl; X is a phenyl group; R′ is H or C1-C4 alkyl; each R1 is independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereof
REFERENCES:
patent: 4956388 (1990-09-01), Robertson et al.
patent: 5023269 (1991-06-01), Robertson et al.
patent: 1295447 (1972-11-01), None
patent: 1412546 (1975-11-01), None
patent: 2167407 (1986-05-01), None
patent: WO-99-15177 (1999-04-01), None
patent: WO-00-39091 (2000-07-01), None
patent: WO-01-01973 (2001-01-01), None
patent: WO-2004-017977 (2004-03-01), None
Clark Barry Peter
Gallagher Peter Thaddeus
Haughton Helen Louise
Anderson Arvie J.
Anderson Rebecca
Eli Lilly and Company
Titus Robert D.
LandOfFree
Benzyl morpholine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzyl morpholine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzyl morpholine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3856895